ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000250410.1	Ponatinib	Bladder urothelial carcinoma	0.031162359	Resistant
ENSG00000250410.1	Ponatinib	Stomach adenocarcinoma	0.003304539	Sensitive